Patent Oppositions in medicine pills and tablets industry

Explore the competitive field of medicine pills and tablets where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in medicine pills and tablets technology and learn how to protect your intellectual property.

Get Patent Opposition Report for medicine pills and tablets

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Report

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the medicine pills and tablets industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the medicine pills and tablets industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Oct 30, 2025
Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the medicine pills and tablets industry

Tablets Comprising Eltrombopag OlamineNOVARTISSep 9, 2025ELKINGTON AND FIFE
Sodium (2R, 5S, 13Ar) -7, 9-Dioxo-10- ( (2,4,6-Trifluorobenzyl) Carbamoyl) -2, 3, 4, 5, 7, 9, 13, 13A-Octahydro-2, 5-Methanopyrido [1',2' : 4.5] Pyrazino [2, 1-B] Oxazepin-8-OlateGILEAD SCIENCESSep 4, 2025BRAND MURRAY FULLER
Pharmaceutical FormulationsGILEAD SCIENCESSep 4, 2025ELKINGTON AND FIFE
Sodium (2R, 5S, 13Ar) -7, 9-Dioxo-10- ( (2,4,6-Trifluorobenzyl) Carbamoyl) -2, 3, 4, 5, 7, 9, 13, 13A-Octahydro-2, 5-Methanopyrido [1',2' : 4.5] Pyrazino [2, 1-B] Oxazepin-8-OlateGILEAD SCIENCESSep 3, 2025KRAUS & LEDERER PARTGMBB
LozengeALTRIA CLIENT SERVICESSep 3, 2025PHILIP MORRIS
Pharmaceutical FormulationsGILEAD SCIENCESSep 3, 2025EIP
Sodium (2R, 5S, 13Ar) -7, 9-Dioxo-10- ( (2,4,6-Trifluorobenzyl) Carbamoyl) -2, 3, 4, 5, 7, 9, 13, 13A-Octahydro-2, 5-Methanopyrido [1',2' : 4.5] Pyrazino [2, 1-B] Oxazepin-8-OlateGILEAD SCIENCESSep 2, 2025HAMM & WITTKOPP
Pharmaceutical FormulationsGILEAD SCIENCESSep 2, 2025HAMM & WITTKOPP
New Use Of A Combination Of Sacubitril And ValsartanNOVARTISSep 1, 2025CAMULON
Tablets Comprising Eltrombopag OlamineNOVARTISAug 5, 2025STADA ARZNEIMITTEL

To stay ahead in the competitive medicine pills and tablets industry, companies are constantly innovating. Here are the top patents facing oppositions in the medicine pills and tablets industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Oct 30, 2025
Patent NumberGrant DateTitleApplicantTotal Oppositions
Jan 17, 2024Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIM19
Nov 13, 2019Apixaban FormulationsBRISTOL MYERS SQUIBB IRELAND12
Dec 11, 2019Rapid Dissolution Formulation Of A Cinacalcet HclAMGEN12
Aug 18, 2021Formulations Of EnzalutamideASTELLAS PHARMA12
May 10, 2017Pharmaceutical Preparation Containing Oxycodone And NaloxoneMUNDIPHARMA11
May 10, 2017Pharmaceutical Preparation Containing Oxycodone And NaloxoneMUNDIPHARMA11
Nov 27, 2019Rapid Dissolution Formulation Of A Calcium Receptor-Active CompoundAMGEN10
Oct 16, 2019Apixaban FormulationsPFIZER10
Oct 16, 2019Apixaban FormulationsBRISTOL MYERS SQUIBB IRELAND UNLIMITED10
Dec 5, 2018Apixaban FormulationsBRISTOL MYERS SQUIBB IRELAND10